Biotechnical Marketing Strategy, Pharmaceutical Research, CRO

News & Events

February 12-14, 2012

The Drug Discovery for Neurodegeneration conference advances drug discovery for neurodegenerative diseases by educating scientists on the process of translating basic research into novel therapies.
The course is designed to give participants knowledge and relevant resources about this field of scientific investigation and address the associated barriers and challenges.

The program will focus on Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis and Multiple Sclerosis.

March 7-10, 2012

27th International Conference of Alzheimer´s Disease International in London, United Kingdom

Conceived as ‘three conferences in one’, under the theme Science, Fact, Fiction, parallel sessions will focus on these three strands bringing them all together into exciting plenaries and debates that concern us all. This ensures that the conference will be valuable for professionals, scientists, researchers, policy makers, people living with dementia, informal and professional carers and all Alzheimer association staff and volunteers alike.

March 27-29, 2012

The objective of the 2012 Research & Standardisation in Alzheimer's Disease Conference (RASAD 2012) is to bring together a selected group of key researchers, clinicians, industry, regulatory and government leaders in Alzheimer's disease to generate consensus on standardisation and validation for clinical practice of psychometrics, imaging, biomarkers and lifestyle parameters used in multiple centres around the world.

May 09-12, 2012

The major focus of the 2012 Stockholm meeting will be on new targets and drugs for the treatment of Alzheimer's disease. The World's leaders in the field will discuss new trial designs, animal models, neuroimaging including PET and diagnostic recommendations as well as CSF and blood markers. Emerging Novel Therapeutic Targets will be presented and a session on oral communications will be open to young scientists. We expect approximately 1500 participants, mostly neurologists, psychiatrists, geriatricians and pharmacologists.

June 17-21, 2012

16th International Congress of Parkinson´s Disease and Movement Disorders in Dublin, Ireland

The 2012 International Congress will be held in The Convention Centre Dublin, designed by Kevin Roche. This is Ireland's world class, purpose built international conference and event venue. Prepare to experience a location like no other, right in the heart of Dublin (UNESCO City of Literature). We look forward to coming together to learn about the latest research and advancements, collaborate with colleagues and actively participate in the advancing field of Movement Disorders, all while enjoying the history, literature, sights, sounds, and tastes of ancient Dublin.

July 14-18, 2012

8th FENS Forum of Neuroscience in Barcelona, Spain

The FENS Forum is a biennial neuroscience conference organised by FENS. With nearly 7000 participants, it has become the largest neuroscience meeting in Europe.
With plenary and special lectures, technical workshops and symposia, and a wealth of poster communications, it is a must for neuroscientists from all over the world.
 

July 14-19, 2012

At AAIC 2012, join the world's leading dementia scientists to share the latest thoughts and theories in the field — and spark new ideas along the way. Listen as experts examine current studies and discuss promising developments. Share your work, advance emerging models and shape new ideas.

September, 2012

13th International Conference on Alzheimer’s Drug Discovery in Jersey City, New Jersey

This annual conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. The ADDF’s funded investigators and top level scientist in the field will present their current research, provide progress updates and stimulate discussion. The conference offers ample opportunities for collaboration and partnering. 

October 10-13, 2012

Again, the Alzheimer Disease Societies Croatia invited numerous national and international speakers, with the intention to present the newest scientific knowledge in the field of Alzheimer's Disease (AD) and other dementia. As in the last Congress, we will ensure simultaneous translation (from English to Croatian) of invited speakers' lectures, which will surely contribute to greater interaction between all participants. Along with the clinical and basic topics in the AD area, we will pay special attention to those related to patients and care givers.

October 13-17, 2012

Neuroscience 2012 in New Orleans, Louisiana

Neuroscience 2012 is the premier venue for neuroscientists from around the world to debut cutting-edge research on the brain and nervous system.

March 6-10, 2013

AD/PD 2013 in Florence, Italy

AD/PD™ Florence will unite international medical professionals for a dynamic scientific program revealing cutting-edge research and discoveries in diagnosing, preventing and treating neurodegenerative diseases.

October 1-4, 2013

2nd World Parkinson Congress in Montreal, Canada

The World Parkinson Congresses provide an international forum for the latest scientific discoveries, medical practices and care initiatives related to Parkinson's disease. By bringing physicians, scientists, nurses, rehab professionals, care partners and people with Parkinson's disease together, we hope to create a worldwide dialogue that will help expedite the discovery of a cure and best treatment practices for this devastating disease.

November 12-16, 2011

Neuroscience 2011 in Washington, USA

Neuroscience 2011 is the premier venue for neuroscientists from around the world to debut cutting-edge research on the brain and nervous system. Check back regularly for updates and announcements.

 

 November 12-17, 2011

20th World Congress of Neurology in Marrakesh, Morocco

With Africa, for Africa, WCN 2011 provides neurologists in Africa with a unique opportunity to join colleagues from around the world for the largest scientific event in neurology. Discover scientific achievements and interact with delegates of diverse backgrounds and perspectives to find real solutions to improve the long-term outcomes for patients with neurological disorders.